Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$29.00 – $29.00
No one on the platform currently holds HTSUF.
No tracked institution reports a position in HTSUF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-08-29 | $45.0000 | 2025-11-06 |
| 2025-08-29 | $15.0000 | 2025-11-06 |
| 2025-02-28 | $2.0000 | 2025-05-23 |
| 2025-02-28 | $43.0000 | 2025-05-23 |
| 2024-08-30 | $43.0000 | 2024-11-07 |
| 2024-08-30 | $2.0000 | 2024-11-07 |
| 2024-02-28 | $42.5000 | 2024-05-24 |
| 2023-08-30 | $42.5000 | 2023-11-07 |
No one on the platform has traded HTSUF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $171.2B | +5.4% | $297.27 | $297.27–$297.27 | 0.1× | 1 |
| 2028 | $178.3B | +4.2% | $324.20 | $324.20–$324.20 | 0.1× | 1 |
| 2029 | $186.4B | +4.6% | $366.77 | $366.77–$366.77 | 0.1× | 1 |
| 2030 | $195.1B | +4.6% | $410.45 | $410.45–$410.45 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-13 | $0.32 | $0.66 | +102.8% |
| 2026-01-06 | $0.37 | $0.44 | +18.4% |
| 2025-10-09 | $0.42 | $0.42 | +0.6% |
| 2025-07-10 | $0.48 | $0.24 | -48.9% |
| 2025-04-10 | $0.33 | $0.73 | +122.2% |
| 2025-01-09 | $0.37 | $0.42 | +11.5% |
| 2024-10-10 | $0.27 | $0.40 | +48.5% |
| 2024-07-11 | $0.28 |
| $0.41 |
| +46.6% |
| +0.00% |
| $3.8B |
| — |
| CURLFCuraleaf Holdings, Inc. | $9.30 | -3.79% | $2.5B | — |
| DMPHFDermapharm Holding SE | $47.69 | +0.00% | $2.4B | — |
Source: Financial Modeling Prep · peers by sector/industry